IRCT201402078307N5已完成2 期
A Randomized placebo controlled trial of Omega-3 on Plasma Level of Cardiac Troponin-I and Creatinine Kinase- MB in patients with myocardial infarctions who undergoing streptokinase therapy
Vice chancellor for research of Tabriz University of Medical Sciences.0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •myocardial infarction patients; age 18-80; undergoing of thrombolytic therapy with streptokinase; filling of consent form.
排除标准
- •Elevation of CK-MB and cTnI before injection of streptokinase; history of CABG during last three months; history of previous MI; renal dysfunction (creatinine above 2.5 mg/dl); contraindication of streptokinase therapy; acute MI; cardiogenic shock; Hypersensitivity to aspirin or clopidogrel or omega-3 and streptokinase injection.
研究者
相似试验
进行中（未招募）
不适用
A Phase III randomized, placebo-controlled study of sorafenib in patients with advanced hepatocellular carcinomaEUCTR2004-001773-26-DEBayer HealthCare AG, D-51368 Leverkusen Germany560
进行中（未招募）
不适用
A Phase III randomized, placebo-controlled study of sorafenib in patients with advanced hepatocellular carcinoma** Amendment 1 Version 2.0 of December 13th 2004 is also includedAdvanced hepatocellular carcinomaMedDRA version: 7.1Level: LLTClassification code 10049010EUCTR2004-001773-26-BEBayer HealthCare AG560
已完成
3 期
A Phase III randomized, placebo-controlled study of sorafenib in patients with advanced hepatocellular carcinomaAdvanced hepatocellular carcinoma.Cancer - LiverACTRN12605000644662Bayer Australia Ltd602
进行中（未招募）
1 期
A Phase III randomized, placebo-controlled study of sorafenib in patients with advanced hepatocellular carcinomaAdvanced hepatocellular carcinomaMedDRA version: 7.1 Level: LLT Classification code 10049010EUCTR2004-001773-26-ESBayer HealthCare AG, D-51368 Leverkusen Germany
进行中（未招募）
3 期
Testing the addition of the immunotherapy drug pembrolizumab to the usual chemotherapy treatment (paclitaxel and carboplatin) in endometrial cancerEndometrial CancerJPRN-jRCT2031210512Fujiwara Keiichi60